WHO ICTRP trial
Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate…
NL-OMON54194 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON54194 |
|---|---|
| Public title | Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation |
| Scientific title | Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation - IBsolvMIR in islet transplantation |
| Primary sponsor | TIKOMED AB |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Netherlands;Norway;Sweden |
| Conditions | Type 1 diabetes youth onset diabetes;10018424;Type 1 diabetes;youth onset diabetes |
| Interventions | IBsolvmir (low molecular weight dextran sulphate) instead of heparin during islet transplantation ;IBMIR;Islet transplantation;Type 1 diabetes |
| Registration date | Apr 6, 2023 |
| Target size | 6 |
| Secondary IDs | 2016-001867-35;NCT03867851;NL78894.058.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: